Peptide YY Reverses TNF-α Induced Transcription Factor Binding of Interferon Regulatory Factor-1 and p53 in Pancreatic Acinar Cells

Journal of Surgical Research

Volumn 136, Issue 1, 2006, Pages 25-30

  Rizvi, Irfan A ^a   Robinson, Kristine ^b   McFadden, David W ^a   Riggs, Dale R ^a   Jackson, Barbara J ^a   Vona Davis, Linda ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

acinar cells; IRF 1; p53; peptide YY; TNF ; transcription factors

Indexed keywords

AMYLASE; DNA; INTERFERON REGULATORY FACTOR 1; NUCLEAR PROTEIN; PEPTIDE YY; PROTEIN P53; TRANSCRIPTION FACTOR;

ACINAR CELL; ANIMAL CELL; ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DENSITOMETRY; DISEASE COURSE; DNA MICROARRAY; ENZYME ACTIVITY; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SPECTROFLUOROMETRY;

ACUTE DISEASE; AMYLASES; ANIMALS; CELL LINE; INTERFERON REGULATORY FACTOR-1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS, EXOCRINE; PANCREATITIS; PEPTIDE YY; PROTEIN BINDING; RATS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750324210     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.028     Document Type: Article

References (45)

1. Lowenfels A.B., Sullivan T., Fiorianti J., and Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep 7 (2005) 90
2. Wassef W., and Zfass A.M. Gallstone pancreatitis: An update. Gastroenterologist 4 (1996) 70
3. Bhatia M., Wong F.L., Cao Y., Lau H.Y., Huang J., Puneet P., and Chevali L. Pathophysiology of acute pancreatitis. Pancreatology 5 (2005) 132
4. Raraty M.G., Connor S., Criddle D.N., Sutton R., and Neoptolemos J.P. Acute pancreatitis and organ failure: Pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 6 (2004) 99
5. Gomez-Cambronero L.G., Sabater L., Pereda J., et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: Therapeutical implications. Curr Drug Targets Inflamm Allergy 1 (2002) 393
6. Savkovic V., Gaiser S., Iovanna J.L., and Bodeker H. The stress response of the exocrine pancreas. Dig Dis 22 (2004) 239
7. Shi C., Zhao X., Wang X., and Andersson R. Role of nuclear factor-kappaB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis. Scand J Gastroenterol 40 (2005) 103
8. Makhija R., and Kingsnorth A.N. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 9 (2002) 401
9. Cavallini G., and Frulloni L. Somatostatin and octreotide in acute pancreatitis: The never-ending story. Dig Liver Dis 33 (2001) 192
10. Reed K., and McFadden D. Peptide YY reduces the mortality of necrotizing pancreatitis. Gastroenterology (1997) 112
11. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion 79 (1982) 2514 Proceedings Of The National Academy Of Sciences Of The United States Of America
12. Pappas T.N., Debas H.T., and Taylor I.L. Peptide YY: Metabolism and effect on pancreatic secretion in dogs. Gastroenterology 89 (1985) 1387
13. Guan D., Rivard N., Morisset J., and Greeley Jr. G.H. Effects of peptide YY on the growth of the pancreas and intestine. Endocrinology 132 (1993) 219
14. Liu C.D., Balasubramaniam A., Saxton R.E., Paiva M., and McFadden D.W. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J Surg Res 58 (1995) 707
15. Bilchik A.J., Hines O.J., Adrian T.E., et al. Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo. Gastroenterology 105 (1993) 1441
16. Lundberg J.K., Tatemoto K., Terenius L., et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility 79 (1982) 4471 Proceedings Of The National Academy Of Sciences Of The United States Of America
17. Pappas T.N., Debas H.T., and Taylor I.L. Peptide YY: Metabolism and effect on pancreatic secretion in dogs. Gastroenterology 89 (1985) 1387
18. Suzuki T., Nakaya M., Itoh Z., Tatemoto K., and Mutt V. Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs. Gastroenterology 85 (1983) 114
19. Chance W.T., Zhang X., Balasubramaniam A., and Fischer J.E. Preservation of intestine protein by peptide YY during total parenteral nutrition. Life Sci 58 (1996) 1785
20. Vona-Davis L., Yu A., Magabo K., Evans T., Jackson B., Riggs D., and McFadden D. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis. J Am Coll Surg 199 (2004) 87
21. Robinson K.S., Vona-Davis L., Riggs D., Jackson B., and McFadden D.W. Peptide YY attentuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J. J Am Coll Surg 202 (2006) 788
22. Tanaka N., Ishihara M., Kitagawa M., et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77 (1994) 829
23. Taniguchi T. Transcription factors IRF-1 and IRF-2: Linking the immune responses and tumor suppression. J Cell Physiol 173 (1997) 128
24. Dornan D., Eckert M., Wallace M., et al. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53. Mol Cell Biol 24 (2004) 10083
25. Christophe J. Pancreatic tumoral cell line AR42J: An amphicrine model. Am J Physiol 266 (1994) G963
26. Gukovskaya A.S., Gukovsky I., Zaninovic V., et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100 (1997) 1853
27. Satoh A., Gukovskaya A.S., Edderkaoui M., et al. Tumor necrosis factor-alpha mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosine kinase 2. Gastroenterology 129 (2005) 639
28. Yang J., Denham W., Tracey K.J., Wang H., Kramer A.A., Salhab K.F., and Norman J. The physiologic consequences of macrophage pacification during severe acute pancreatitis. Shock 10 (1998) 169
29. Bilchik A.J., Leach S.D., Zucker K.A., and Modlin I.M. Experimental models of acute pancreatitis. J Surg Res 48 (1990) 639
30. Gross V., Leser H.G., Heinisch A., and Scholmerich J. Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis?. Hepatogastroenterology 40 (1993) 522
31. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11 (1983) 1475
32. Gomez G., Lee H.M., He Q., Englander E.W., Uchida T., and Greeley Jr. G.H. Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med (Maywood) 226 (2001) 692
33. Watanabe O., Baccino F.M., Steer M.L., and Meldolesi J. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: Early morphological changes during development of experimental pancreatitis. Am J Physiol 246 (1984) G457
34. Kazanjian K.K., Towfigh S., and McFadden D.W. Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro. J Surg Res 114 (2003) 95
35. Reed K., and McFadden D. Peptide YY suppresses serum IL-6 and TNF-alpha levels in a murine model of acute pancreatitis. Surg Forum 48 (1997) 179
36. Tito J.M., Rudnicki M., Jones D.H., Alpern H.D., and Gold M.S. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat. Am J Surg 165 (1993) 690
37. Vona-Davis L.C., Frankenberry K.A., Waheed U., Peterson E., and McFadden D.W. Expression of STAT3 and SOCS3 in pancreatic acinar cells. J Surg Res 127 (2005) 14
38. Baker M.S., Chen X., Rotramel A.R., Nelson J.J., and Kaufman D.B. Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. Surgery 134 (2003) 134
39. Tanaka N., Ishihara M., Lamphier M.S., et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382 (1996) 816
40. Kano A., Haruyama T., Akaike T., and Watanabe Y. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun 257 (1999) 672
41. Lamb P., Seidel H.M., Haslam J., et al. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res 23 (1995) 3283
42. Lee A.H., Hong J.H., and Seo Y.S. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 1 (2000) 131
43. Meraz M.A., White J.M., Sheehan K.C., et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431
44. Durbin J.E., Hackenmiller R., Simon M.C., and Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 (1996) 443
45. Dornan D., Eckert M., Wallace M., et al. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53. Mol Cell Biol 24 (2004) 10083